International Journal of Molecular Sciences (Sep 2022)

Somatic Mutational Landscape in Mexican Patients: <i>CDH1</i> Mutations and chr20q13.33 Amplifications Are Associated with Diffuse-Type Gastric Adenocarcinoma

  • Dennis Cerrato-Izaguirre,
  • Yolanda I. Chirino,
  • Diddier Prada,
  • Ericka Marel Quezada-Maldonado,
  • Luis A Herrera,
  • Angélica Hernández-Guerrero,
  • Juan Octavio Alonso-Larraga,
  • Roberto Herrera-Goepfert,
  • Luis F. Oñate-Ocaña,
  • David Cantú-de-León,
  • Abelardo Meneses-García,
  • Patricia Basurto-Lozada,
  • Carla Daniela Robles-Espinoza,
  • Javier Camacho,
  • Claudia M. García-Cuellar,
  • Yesennia Sánchez-Pérez

DOI
https://doi.org/10.3390/ijms231911116
Journal volume & issue
Vol. 23, no. 19
p. 11116

Abstract

Read online

The Hispanic population, compared with other ethnic groups, presents a more aggressive gastric cancer phenotype with higher frequency of diffuse-type gastric adenocarcinoma (GA); this could be related to the mutational landscape of GA in these patients. Using whole-exome sequencing, we sought to present the mutational landscape of GA from 50 Mexican patients who were treated at The Instituto Nacional de Cancerología from 2019 to 2020. We performed a comprehensive statistical analysis to explore the relationship of the genomic variants and clinical data such as tumor histology and presence of signet-ring cell, H. pylori, and EBV. We describe a potentially different mutational landscape between diffuse and intestinal GA in Mexican patients. Patients with intestinal-type GA tended to present a higher frequency of NOTCH1 mutations, copy number gains in cytobands 13.14, 10q23.33, and 12q25.1, and copy number losses in cytobands 7p12, 14q24.2, and 11q13.1; whereas patients with diffuse-type GA tended to present a high frequency of CDH1 mutations and CNV gains in cytobands 20q13.33 and 22q11.21. This is the first description of a mutational landscape of GA in Mexican patients to better understand tumorigenesis in Hispanic patients and lay the groundwork for discovering potential biomarkers and therapeutic targets.

Keywords